TEVA in the 13F filings
Teva Pharmaceutical Inds LTD · CUSIP 881624209
- Quarter end
- 31 Dec 2025
- the date the book describes
- Filed
- 27 Oct 2026
- latest of these filings; the earliest 5 Feb 2026
- Managers listing it
- 34
- at least, of 95 tracked, among listed positions
- Comparable managers
- 92
- filed both Q3 2025 and Q4 2025; 11 listed it in both
- Shares listed
- 78,204,713
- combined, among listed positions
- Reported value
- $2.4bn
- combined, at the quarter end
Among the 92 comparable managers: 18 buyers (opened or added shares) and 22 sellers (trimmed or exited), at least, among listed positions. Their net change in shares was -6,368,785.
Managers listing TEVA in Q4 2025
34 of 34 holders
Largest increases and reductions, by shares
Increases
- Fidelity (FMR LLC)existing position · 29,014,982 shares now+4,373,620
- Citadel Advisors LLCexisting position · 3,847,855 shares now+2,613,700
- Capital World Investorsnew position · 2,361,012 shares now+2,361,012
- T. Rowe Price Associates Incexisting position · 1,559,602 shares now+1,050,901
- D. E. Shaw & Co.existing position · 647,111 shares now+477,944
Reductions
- Farallon Capital Management LLCexisting position · 40,000 shares now-4,957,000
- Jane Street Group LLCexisting position · 1,618,879 shares now-1,384,754
- Susquehanna International Group LLPexisting position · 75,713 shares now-750,545
- Greenlight Capitalexisting position · 3,058,734 shares now-720,043
- Steadfast Capital Management LPexisting position · 475,461 shares now-322,539
New positions and exits
New (5)
Exited (6)
- Maverick Capital Ltdwas $87m
- Viking Global Investors LPwas $51m
- Millennium Management LLCwas $22m
- Renaissance Technologies LLCwas $20m
- Rokos Capital Management LLPwas $15m
- Walleye Capital LLCwas $1.4m
Ownership over time
Tracked managers listing it, at least.
| Quarter | Holders | Reported value | Buyers | Sellers |
|---|---|---|---|---|
| Q2 2013 | 14 | $5.5bn | n.a. | n.a. |
| Q3 2013 | 16 | $5.9bn | n.a. | n.a. |
| Q4 2013 | 17 | $5.4bn | n.a. | n.a. |
| Q1 2014 | 24 | $7.7bn | n.a. | n.a. |
| Q2 2014 | 24 | $7.3bn | n.a. | n.a. |
| Q3 2014 | 25 | $7.4bn | n.a. | n.a. |
| Q4 2014 | 25 | $8.1bn | n.a. | n.a. |
| Q1 2015 | 25 | $8.7bn | n.a. | n.a. |
| Q2 2015 | 26 | $8.2bn | n.a. | n.a. |
| Q3 2015 | 23 | $8.4bn | n.a. | n.a. |
| Q4 2015 | 25 | $12.8bn | n.a. | n.a. |
| Q1 2016 | 27 | $10.3bn | n.a. | n.a. |
| Q2 2016 | 22 | $8.8bn | n.a. | n.a. |
| Q3 2016 | 25 | $7.9bn | n.a. | n.a. |
| Q4 2016 | 19 | $6.6bn | n.a. | n.a. |
| Q1 2017 | 22 | $5.9bn | n.a. | n.a. |
| Q2 2017 | 14 | $6.2bn | n.a. | n.a. |
| Q3 2017 | 15 | $3.0bn | n.a. | n.a. |
| Q4 2017 | 14 | $4.1bn | n.a. | n.a. |
| Q1 2018 | 13 | $4.8bn | n.a. | n.a. |
| Q2 2018 | 18 | $7.0bn | n.a. | n.a. |
| Q3 2018 | 18 | $6.3bn | n.a. | n.a. |
| Q4 2018 | 19 | $4.9bn | n.a. | n.a. |
| Q1 2019 | 14 | $4.7bn | n.a. | n.a. |
| Q2 2019 | 14 | $2.8bn | n.a. | n.a. |
| Q3 2019 | 11 | $2.0bn | n.a. | n.a. |
| Q4 2019 | 9 | $2.9bn | n.a. | n.a. |
| Q1 2020 | 14 | $2.0bn | n.a. | n.a. |
| Q2 2020 | 12 | $2.8bn | n.a. | n.a. |
| Q3 2020 | 7 | $2.1bn | n.a. | n.a. |
| Q4 2020 | 5 | $2.2bn | n.a. | n.a. |
| Q1 2021 | 8 | $2.6bn | n.a. | n.a. |
| Q2 2021 | 7 | $2.1bn | n.a. | n.a. |
| Q3 2021 | 6 | $1.7bn | n.a. | n.a. |
| Q4 2021 | 4 | $1.1bn | n.a. | n.a. |
| Q1 2022 | 9 | $1.4bn | n.a. | n.a. |
| Q2 2022 | 11 | $913m | n.a. | n.a. |
| Q3 2022 | 11 | $1.4bn | n.a. | n.a. |
| Q4 2022 | 11 | $1.7bn | n.a. | n.a. |
| Q1 2023 | 8 | $1.3bn | n.a. | n.a. |
| Q2 2023 | 10 | $184m | n.a. | n.a. |
| Q3 2023 | 13 | $384m | n.a. | n.a. |
| Q4 2023 | 10 | $373m | 8 | 3 |
| Q1 2024 | 16 | $666m | 8 | 6 |
| Q2 2024 | 22 | $1.8bn | 13 | 7 |
| Q3 2024 | 22 | $2.3bn | 9 | 12 |
| Q4 2024 | 18 | $3.0bn | 8 | 11 |
| Q1 2025 | 12 | $2.0bn | 7 | 6 |
| Q2 2025 | 11 | $1.8bn | 6 | 5 |
| Q3 2025 | 14 | $964m | 9 | 4 |
| Q4 2025 | 16 | $2.1bn | 18 | 22 |
| Q1 2026 | 14 | $2.0bn | 20 | 19 |
| Q2 2026 | 14 | $2.4bn | 18 | 16 |
Compare with…
Holders over time, buyers and sellers, and the managers holding both, side by side for up to four stocks.
TEVA and LLY →TEVA and JNJ →TEVA and VRTX →Choose a stock to compare with TEVA →
How much of the picture this is
A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. It shows no shorts, cash, bonds or performance, and it is never today’s portfolio. Large books are listed to their largest positions, so a manager missing from this table may still hold a small position below that line. These are 95 tracked managers, not the institutional market.
Which funds own TEVA, latest filings →Back to the 13F Explorer →